Literature DB >> 25244342

Clinical Oncology Society of Australia position statement on the use of complementary and alternative medicine by cancer patients.

Lesley Braun1, Jessica Harris, Paul Katris, Michael Cain, Haryana Dhillon, Bogda Koczwara, Ian Olver, Monica Robotin.   

Abstract

Health professionals involved in the clinical management of cancer are becoming increasingly aware that their patients use complementary and alternative medicine (CAM). As cancer incidence and survival rates increase, use of CAM is also likely to increase. This paper outlines the position of the Clinical Oncology Society of Australia (COSA) on the use of CAM by cancer patients and provides guidance for health professionals involved with the treatment of cancer patients who are using or wish to use CAM. Key definitions and common communication scenarios are presented along with evidence-based recommended steps for health professionals when discussing CAM use. COSA encourages health professionals to focus on open discussion with their patients regarding CAM, to become familiar with reputable resources for CAM information, to discuss with patients the concept of evidence-based medicine, to recognize limitations to their knowledge of CAM and seek further advice when necessary, and to be respectful of the patients' right to autonomy.
© 2014 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  complementary therapy; informed consent; integrative medicine; neoplasm; physician-patient relation

Mesh:

Year:  2014        PMID: 25244342     DOI: 10.1111/ajco.12227

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN: 1743-7555            Impact factor:   2.601


  11 in total

1.  Guidance for establishing an integrative oncology service in the Australian healthcare setting-a discussion paper.

Authors:  Suzanne J Grant; Jennifer Hunter; Alan Bensoussan; Geoff P Delaney
Journal:  Support Care Cancer       Date:  2017-09-01       Impact factor: 3.603

2.  Perceptions, opinions and knowledge of pharmacists towards the use of complementary medicines by people living with cancer.

Authors:  Joanna Harnett; Trong Quy Le; Lorraine Smith; Ines Krass
Journal:  Int J Clin Pharm       Date:  2018-05-09

3.  Oncologists' experiences of discussing complementary and alternative treatment options with their cancer patients. A qualitative analysis.

Authors:  Güthlin Corina; Holmberg Christine; Gudrun Klein
Journal:  Support Care Cancer       Date:  2016-04-14       Impact factor: 3.603

4.  Exploring the Use of Complementary and Alternative Medicine in Cancer Patients.

Authors:  Ellen Jones; Lisa Nissen; Alexandra McCarthy; Kathryn Steadman; Carol Windsor
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

Review 5.  Exploring the Use of Complementary and Alternative Medicine in Cancer Patients.

Authors:  Ellen Jones; Lisa Nissen; Alexandra McCarthy; Kathryn Steadman; Carol Windsor
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

6.  Complementary and Integrative Medicine Use in Individuals Seeking Conventional Medical Oncology Care in Chile: Prevalence and Patient Characteristics.

Authors:  Gabriel Lopez; Claudio Alejandro Salas; Fernando Cadiz; Carolina Barriga; Pilar Gonzalez; Sandra Acevedo; Patricia Raimilla; Pia Pincheira; Aung Naing; Marta Quiroga
Journal:  J Glob Oncol       Date:  2019-05

7.  Complementary and alternative therapy use in a regional radiation oncology treatment centre: Can staff knowledge, views, confidence and documentation be improved?

Authors:  Lisa J Delaney; Stephen J Manley
Journal:  J Med Radiat Sci       Date:  2019-08-08

Review 8.  Exploring Herbal Medicine Use during Palliative Cancer Care: The Integrative Physician as a Facilitator of Pharmacist-Patient-Oncologist Communication.

Authors:  Noah Samuels; Eran Ben-Arye
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-11

9.  Integrative oncology and complementary medicine cancer services in Australia: findings from a national cross-sectional survey.

Authors:  Caroline A Smith; Jennifer Hunter; Geoff P Delaney; Jane M Ussher; Kate Templeman; Suzanne Grant; Eleanor Oyston
Journal:  BMC Complement Altern Med       Date:  2018-10-29       Impact factor: 3.659

Review 10.  Combination therapy for metastatic melanoma: a pharmacist's role, drug interactions & complementary alternative therapies.

Authors:  Gabriel Gazzé
Journal:  Melanoma Manag       Date:  2018-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.